Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Citigroup Adjusts Medtronic's Price Target to $146 From $153, Reiterates Buy Rating

11/24/2021 | 07:00am EST


ę MT Newswires 2021
All news about MEDTRONIC PLC
01/26Titan Medical Receives Milestone Net Payment of $8.3M
DJ
01/25WALL STREET STOCK EXCHANGE : A roller-coaster week as Fed decision looms
01/24Medtronic Facing Currency, COVID-19 Headwinds, Needham Says
MT
01/24Needham Lowers Medtronic's Price Target to $128 From $131 To Reflect Increased Currency..
MT
01/24Medtronic Receives FDA Approval For Spinal Cord Stimulation for Chronic Pain Due to Dia..
MT
01/24Medtronic Gets FDA Approval for Neurostimulators to Treat Chronic Pain From Diabetic Pe..
MT
01/24Medtronic Announces FDA Approval of Spinal Cord Stimulation Therapy for Treating Chroni..
CI
01/21Health Care Stocks Retreat This Afternoon
MT
01/21Health Care Stocks Drifting Lower in Friday Trade
MT
01/21SVB Leerink Adjusts Medtronic Price Target to $115 From $138, Maintains Market Perform ..
MT
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 298 M - -
Net income 2022 5 521 M - -
Net Debt 2022 21 686 M - -
P/E ratio 2022 25,7x
Yield 2022 2,41%
Capitalization 140 B 140 B -
EV / Sales 2022 5,00x
EV / Sales 2023 4,67x
Nbr of Employees 90 000
Free-Float -
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 104,09 $
Average target price 128,80 $
Spread / Average Target 23,7%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz President-Medtronic Neuromodulation & SVP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC0.70%139 955
ABBOTT LABORATORIES-14.69%205 916
BECTON, DICKINSON AND COMPANY2.63%72 370
HOYA CORPORATION-13.88%47 540
BAXTER INTERNATIONAL INC.-1.83%42 193
SARTORIUS STEDIM BIOTECH-23.51%38 378